Skip to main content
. 2024 Apr 12;13(7):e7132. doi: 10.1002/cam4.7132

TABLE 1.

Basic characteristics of 1297 patients with early‐stage EOC treated with FSS or RCS.

Characteristics FSS (N = 401) (%) RCS (N = 896) (%) p
Age, mean ± SD 32.4 ± 5.9 38.8 ± 4.7 <0.001
Age
<35 years 249 (62.1) 157 (17.5) <0.001
35–39 years 107 (26.7) 253 (28.3)
≥40 years 45 (11.2) 486 (45.2)
Histology
Serous carcinoma 42 (10.5) 81 (9.0) <0.001
Mucinous carcinoma 167 (41.5) 198 (22.1)
Endometrioid carcinoma 75 (21.5) 289 (32.3)
Clear cell carcinoma 70 (17.5) 259 (28.9)
Others a 36 (9.0) 69 (7.7)
Stage
IA + IB 212 (52.9) 365 (40.8) <0.001
IC 168 (41.9) 408 (45.5)
II 21 (5.2) 123 (13.7)
Grade
1 + 2 184 (45.9) 396 (44.2) <0.001
3 109 (27.2) 382 (42.6)
Unknown 108 (26.9) 118 (13.2)
Adjuvant chemotherapy
No 186 (46.4) 198 (22.1) <0.001
Yes 215 (53.6) 698 (77.9)

Abbreviations: EOC, epithelial ovarian cancer; FSS, fertility‐sparing surgery; N, number of patients; NOS, not otherwise specified; RCS, radical comprehensive staging surgery, SD, standard deviation.

a

Others included mixed cell adenocarcinoma; adenocarcinoma, NOS; and carcinoma, NOS.